Treatment Indications: correction of moderate to deep facial wrinkles and folds (including nasolabial folds, marionette lines, glabellar and forehead rhytides), volumizing in high‑demand areas with significant atrophy (cheeks, cheekbones, temples, chin);, structural contouring of jawline, chin, and nasal bridge; correction of facial asymmetry and severe volume deficit;, non‑surgical lifting via deep‑layer volumization;, restoration of facial architecture and skeletal support
Release form: 1 × 1.1 mL pre‑filled sterile glass syringe
Compound: cross‑linked hyaluronic acid (manufactured with HBCT/Hexagonal Block Crosslinking and GI/Grinding Irregular technologies for homogeneous gel structure); lidocaine; phosphate‑buffered saline solution (pH ~7)
Concentration of GC: 24 mg/mL
Lidocaine: 0.3 %
Indications: volumizing and structural contouring in deep subcutaneous and supraperiosteal layers;, restoration of major volume loss and facial skeletal support;, smoothing deep depressions, folds, and scars; providing high‑support, long‑lasting volume with maximal viscoelasticity and minimal product migration